Teva Outlines US Opportunities Amid North American Decline

Future Targets Include Generic Symbicort And Alvotech-Partnered Humira Biosimilar

 
• By David Wallace
  
Target with arrow in bullseye, under magnifying glass
Teva has identified future targets in the US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business